In this episode of Mommy Brain Revisited, Dr Tim Oberlander and I briefly discuss SSRI use in pregnancy and the importance of focusing on maternal mental health in this area of research.

Our conversation centers on our perspective, Potential risks and benefits of prenatal selective serotonin reuptake inhibitor medications for maternal mental health and child development published in Nature Mental Health.

We emphasize the complexity of separating medication effects from underlying maternal depression and the importance of comprehensive approaches, including pharmacologic and non-pharmacologic treatments.

For more on current treatment guidelines for perinatal mental health see:

https://www.canmat.org/2025/02/12/available-now-canmat-2024-guidelines-for-perinatal-mood-anxiety-and-related-disorders-and-accompanying-patient-and-family-guide/

Dr. Tim Oberlander  has over 3 decades of research on maternal mental health, SSRIs and child development. He is a Developmental Pediatrician, Clinician-Scientist and Professor of Pediatrics in the School of Population Public Health, University of British Columbia and BC Children’s Hospital.

Our publication: Pawluski, J., Oberlander, T.F. Potential risksand benefits of prenatal selective serotonin reuptake inhibitor medications for maternal mental health and child development. Nat. Mental Health 3,1304–1310 (2025). https://doi.org/10.1038/s44220-025-00480-w

For more on your host see www.jodipawluski.com or follow Jodi on Instagram or LinkedIn.